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EDWIN J. LEVY, M.D.
The concentration of antimalarials in the
human skin, particularly in regard to the rela-
tive concentrations in epidermis and corium,
has not to our knowledge been reported. Similarly
we have seen no documentation on the effect of
antimalarials in modifying the ultraviolet light
absorption of separated epidermis and corium.
To this end, we have attempted the following
experiments: (1) Measurement of the normal
absorption curves of separated epidermis and
corium spectrophotometrically. (2) Measure-
ment of absorption curves of separated epidermis
and corium taken from normal volunteers each
of whom had ingested one of several aritimalarials
to see if any modification of the curves resulted
from the presence in these tissues of the anti-
malarial drug. (3) Quantitative measurement of
the amount of these drugs in separated epidermis
and corium.
EXPERIMENTAL METHOD
Normal white adult males were used as sub-
jects. With the exception of those who acted as
controls, each individual was given an anti-
malarial in the following dosage schedules:
Quinacrine dihydrochloride (Atabrine), 100 mg.
three times a day for one week, then 100 mg. a
day for three weeks. Chioroquine diphosphate
(Aralen), 250 mg. twice a day for one week,
then 250 mg. a day for three weeks. Hydroxy-
chioroquine sulfate (Plaquenil), 200 mg. twice a
day for one week, then 200 mg. a day for three
weeks. Amodiaquin hydrochloride (Camoquin),
200 mg. twice a day for one week, then 200 mg.
a day for three weeks.
At the end of this period a specimen of skin
from the abdomen was excised under procaine
anesthesia. This measured on the living subject
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1 x 3 cm. The subcutaneous fat was carefully
trimmed off and, after weighing, the skin was
placed in a tightly capped vial, then frozen and
stored in dry ice. After several days it was allowed
to thaw and the epidermis was separated from
the corium using the stretch and mechanical
method as described by Van Scott (1). Each
specimen of epidermis and corium was weighed
separately, again placed in sealed vials, promptly
frozen in dry ice and immediately sent by Air-
Mail to the laboratory for analysis. A histologic
check was made of the separated epidermis and
corium in each case to demonstrate the accuracy
of separation.
In the case of those skin specimens submitted
for spectrophotometric examination each piece
of epidermis and corium was spread out smoothly
between two glass slides so as to maintain its
configuration.
Six biopsy specimens were examined spectro-
photometrically.* Two of these were normal skin
and four from individuals each of whom had
taken one of the antimalarials listed above. The
absorption curves of both epidermis and coriuni
were obtained by supporting these specimens on
the external face of a quartz cell.
Eleven biopsy specimens were obtained from
subjects as follows: Two subjects had been
given quinacrine, two hydroxychloroquine, two
chloroquine, three amodiaquin, and two subjects,
acting as controls, had taken no drug. The
separated epidermis and corium from each of
these specimens were individually minced and
homogenized after which they were examined
by analytical procedures based on iluorimetry.t
Quinacrine was determined by the procedure
described by Brodie et al. (2); chioroquine estima-
tion was based on work by the same authors (3);
amodiaquin was determined using modification
341
* Performed by Dr. J. M. Vandenbelt, Labora-
tory Director in Physicial Chemistry, Parke,
Davis and Co.f Performed in the laboratory of Dr. A. J.
Glazko, Research Department, Parke, Davis and
Co.
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Fia. 1. Ultraviolet absorption spectrum of normal human epidermis
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of the ehioroquine technic involving preliminary
alkaline hydrolysis of the extracted drug; hy-
droxychioroquine readings were made based on
the procedure described by McChesney et al. (4).
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FIG. 2. Ultraviolet absorption spectrum of epi-
dermis from an individual who had ingested
chloroquine. The absorption curve of chioroquine
is superimposed to indicate the absence of any
detectable effect of the drug.
Spectrophotometrie absorption curves of sepa-
rated epidermis and of corium were obtained. In
the case of the epidermis a very considerable
absorption could be demonstrated from the lower
end of the scale at about 2500 A units to approx-
imately 3000 A units (Fig. 1). In specimens of
epidermis taken from individuals who had
ingested the antimalarial drugs the curves were
similar to those of the controls, indicating that
the absorption of the epidermis was so pro-
nounced that any small absorption that the drug
might have had, could not be detected spectro-
photometrically (Fig. 2). Similar work done with
corium produced an absorption curve between
3,400 and 5,200 A units (Fig. 3). Again there
was no perceptible effect of the ingested anti-
malarial on the normal shape of the curve (Fig.
4). This would indicate that the small amount of
drug present in these tissues was not sufficient
to influence significantly the absorption of
ultraviolet light by these tissues. Superimposed
absorption curves of the antimalarials (Fig. 5)
indicate that their principal absorption bands
ABSORPTION SPECTRUM
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FIG. 3. Ultraviolet absorption curve of normal
corium.
FIG. 4. Ultraviolet absorption curve of corium
taken from an individaul who had ingested quin-
acrine. The absorption curve of quinacrine is
superimposed to demonstrate the lack of effect of
this drug in modifying the normal spectral curve.
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FIG. 5. Superimposed absorption curves of antimalarials. Note the absence of uniformity in the shape
of the curves, different spectral positions of the absorption peaks, and absence of absorption peaks
at 2900—3100, A the spectral range most effective in producing many cases of polymorphous light erup-
tion.
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TABLE I
Concentration of various antimalarials in normal
human corium and epidermis
Drug .Subject
Concentration
(Microgram!
Gin.)
Corium
Quinacrine
(Atabrine)
Hydroxy-chioroquine
(Plaquenil)
Chioroquine
(Aralen)
Amodiaquin
(Camoquin)
C. R.
P. A.
R. A.
B. Y.
H. T.
S. S.
A. I.
F. 0.
P.s.
2.7
1.8
1.5
1.4
7.7
3.4
3.6
0.8
1.6
18.1
20.4
22.3
—
25.7
25.9
33.2
17.4
44.1
occur at different points in the spectrum and
that these do not correspond to the normal sun-
burn spectral range. This would indicate that the
antimalarials played little or no role in modifying
the normal absorption of ultraviolet light by
epidermis insofar as sunburn or polymorphous
light eruption is concerned.
In the case of the quantitative analysis of
antimalarial drug present in epidermis and
corium the results were expressed in micrograms
of drug (base) per gm. of tissue (wet weight)
(Table I). All the specimens showed a higher
concentration of the drug in the epidermis than
in the corium. The epidermis/dermis ratio was
about 5 times for chloroquine, 10 times for
quinacrine and 15 times or greater for hydroxy-
chloroquine and amodiaquin.
The drug concentration in the epidermis
ranged from an average low of 19.2 microgram
per gm. in the case of quinacrine to an average
high of 31.6 microgram per gm. for amodiaquin.
A drug concentration of 20 micrograms per gm.
of epidermis would represent about 0.2 micro-
grams per square cm. of epidermis assuming an
average epidermis weight of 0.01 gm. per square
cm. This is certainly a miniscule amount of
material. Therefore, although these drugs seem
to be relatively concentrated in the epidermis,
their actual amount was so small that they could
not offer much of a physical barrier to the passage
of ultraviolet light.
DISCUSSION
It is apparent that in spite of the thinness of
the epidermis (averaging 0.1 mm. in our Speci-
mens) a very considerable absorption of ultra-
violet light takes place. It is generally accepted
that very little ultraviolet light in the Sunburn
spectrum penetrates through the epidermis to
reach the corium (5) and our observations would
Seem to support this opinion. More pertinent to
our study is the insignificant role that the anti-
malarials, already present in the epidermis, play
in absorbing ultraviolet light as demonstrated
by the absence of a modification of the normal
absorption curve of epidermis, this in Spite of
the fact that the drugs tend to be relatively
concentrated in this structure.
Many reports have demonstrated that certain
antimalarial preparations are strongly effective
in suppressing the cutaneous manifestations of
lupus erythematosus and polymorphous light
eruption (6—9). Other work on polymorphouS
light eruption has indicated that the antimalarials
effective in this regard do not act as light filters
but, in some unknown manner, suppress the
specific reaction of the skin involved in this
disease (10—11). In support of this thesis is the
fact that the antimalarials lack any action
whatsoever in subduing the normal sunburn
reaction, which incidently is produced by the
same spectral region (2900—3100 A) responsible
for precipitating many cases of polymorphous
light eruption. Furthermore, the fact that the
antimalarials lack uniform absorption curves,
and have peaks in regions not at all corresponding
to the most effective band in the sunburn spectral
region is added potent evidence for this opinion
(Fig. 5).
These data tend further to substantiate the
thesis that the action of these drugs in suppressing
the manifestations of polymorphous light erup-
tion is other than that of an intraepidermal
sunscreen.
The absorption curve of epidermis obtained
by direct means corresponds closely to the
absorption curve of proteins and is presumably
in great measure due to the amino acids present
in the proteins containing tyrosine and trypto-
phane (5). There appear to be two possible
explanations for the greater concentration of
antimalarials in the epidermis as compared to the
corium, namely: (1) that the antimalarials have
a greater affinity for epidermal protein than those
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of the corium. (2) that, as a result of keratiniza-
tion, the water content of the epidermis is
reduced.
The strong affinity of most antimalarials for
protein is well known (12) and no doubt the
drug remains bound to protein while the epider-
mal cell is being converted into the flattened
corneal cell. On the other hand, the water content
of the total epidermis is approximately 9' that
of the corium (13) so that this relative desicca-
tion could account only partially for the five to
fifteen fold increase in the epidermal concentra-
tion. We must conclude, therefore, that this
increase is due largely to the greater affinity of
these drugs for epidermal proteins.
Preliminary work on the concentration of
antimalarials in the stratum comeum scraped
from the plantar surfaces of the feet of volun-
teers who ingested these drugs on dosage pro-
grams identical with those described above
indicated that (1) antimalarials can be readily
identified quantitatively from this material and
(2) the amount of antimalarial present was of an
order similar to that found in the separated
epidermis. These findings suggest that this
procedure might be a practical clinical method
for determining the effective concentration of
these materials in epidermis.
CONCLUSION
(1) The concentration of some antima].arials
(namely, quinacrine, chloroquine, hydroxychloro-
quine and amodiaquin) in separated epidermis
and corium have been determined in the skin of
normal individuals who had ingested these
drugs.(2) The antimalarials tend to concentrate in
the epidermis vis a vis the corium with an epider-
mis/corium ratio of 5-15:1.
(3) Epidermal concentration of antimalarials
is believed to result largely from the greater
affinity of the antimalarials for epidermal pro-
tein as compared to that of the corium, although
relative desiccation of the epidermis may play a
partial role.
(4) Ultraviolet light absorption curves of
normal human separated epidermis and corium
have been obtained.
(5) Similar absorption curves on tissue taken
from normal volunteers who had ingested anti-
malarials indicated that these drugs had no
perceptible absorption effects insofar as the
ultraviolet spectrum was concerned on either
epidermis or corium.
(6) The amount of antimalarial drug present
in the epidermis is not sufficient to act as a
significant physical barrier to the passage of
ultraviolet light.
(7) The action of antimalarials in suppressing
polymorphous light eruption cannot be due to a
light screening effect.
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